Advertisement
Mayo Clinic Proceedings Home
MCP Digital Health Home

Early-Onset Noncommunicable Disease and Multimorbidity Among Adults With Pediatric-Onset Disabilities

Published:December 03, 2019DOI:https://doi.org/10.1016/j.mayocp.2019.07.010

      Abstract

      Objective

      To determine the prevalence of major noncommunicable diseases among young adults with pediatric-onset disabilities (PoDs) compared with young adults without PoDs.

      Patients and Methods

      Data were obtained from the Optum Clinformatics Data Mart, a de-identified nationwide claims database of beneficiaries from a single private payer in the United States. Beneficiaries were included if they were 18 to 40 years old and had an International Classification of Diseases, Ninth Revision, Clinical Modification diagnostic code for a PoD known to originate in childhood. Diagnostic codes were used to identify high-burden noncommunicable diseases: ischemic heart disease, cerebrovascular disease, hypertensive and other cardiovascular disease, type 2 diabetes, malignant cancer, osteoporosis, mood affective disorders, chronic obstructive pulmonary disease, chronic kidney disease, and liver disease. The prevalence of noncommunicable diseases and multimorbidity (≥2 diseases) was compared between adults with (N=47,077) and without (N=2,180,250) PoDs, before and after adjusting for sociodemographic characteristics. This study was conducted between July 1, 2018, and February 1, 2019.

      Results

      Adults with PoDs had higher prevalences and adjusted odds of all noncommunicable diseases (odds ratio, 2.1-9.0; all P<.05) and multimorbidity (odds ratio, 3.8; 95% CI, 3.7-3.9) compared with adults without PoDs. After stratifying by the type of PoD (eg, musculoskeletal, circulatory), all PoD categories had higher prevalence of all noncommunicable diseases and multimorbidity compared with young adults without PoDs, except for ischemic heart disease and cerebrovascular disease among adults with PoDs of the genital organs.

      Conclusion

      Young adults with PoDs have an early onset of several noncommunicable diseases that represent major contributors to the global and national burden of disease and mortality.

      Abbreviations and Acronyms:

      OR (odds ratio), PoD (pediatric-onset disability)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Murray C.J.
        • Vos T.
        • Lozano R.
        • et al.
        Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
        Lancet. 2012; 380: 2197-2223
        • GBD 2016 Causes of Death Collaborators
        Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.
        Lancet. 2017; 390 ([published correction appears in Lancet. 2017;390(10106):e38]): 1151-1210
        • World Health Organization
        Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020.
        World Health Organization, Geneva, Switzerland2013
        • Whitney D.G.
        • Hurvitz E.A.
        • Ryan J.M.
        • et al.
        Noncommunicable disease and multimorbidity in young adults with cerebral palsy.
        Clin Epidemiol. 2018; 10: 511-519
        • Whitney D.G.
        • Hurvitz E.A.
        • Devlin M.J.
        • et al.
        Age trajectories of musculoskeletal morbidities in adults with cerebral palsy.
        Bone. 2018; 114: 285-291
        • Cremer N.
        • Hurvitz E.A.
        • Peterson M.D.
        Multimorbidity in middle-aged adults with cerebral palsy.
        Am J Med. 2017; 130 (744.e9-744.e15)
        • Hosking F.J.
        • Carey I.M.
        • Shah S.M.
        • et al.
        Mortality among adults with intellectual disability in England: comparisons with the general population.
        Am J Public Health. 2016; 106 ([published correction appears in Am J Public Health. 2016;106(12):e11-e12]): 1483-1490
        • Boyle C.A.
        • Boulet S.
        • Schieve L.A.
        • et al.
        Trends in the prevalence of developmental disabilities in US children, 1997-2008.
        Pediatrics. 2011; 127: 1034-1042
        • Brooks J.C.
        • Strauss D.J.
        • Shavelle R.M.
        • Tran L.M.
        • Rosenbloom L.
        • Wu Y.W.
        Recent trends in cerebral palsy survival, Part I: period and cohort effects.
        Dev Med Child Neurol. 2014; 56: 1059-1064
        • Global Research on Developmental Disabilities Collaborators
        Developmental disabilities among children younger than 5 years in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
        Lancet Glob Health. 2018; 6 ([published correction appears in Lancet Glob Health. 2018;6(12):e1287]): e1100-e1121
        • Verschuren O.
        • Smorenburg A.R.P.
        • Luiking Y.
        • Bell K.
        • Barber L.
        • Peterson M.D.
        Determinants of muscle preservation in individuals with cerebral palsy across the lifespan: a narrative review of the literature.
        J Cachexia Sarcopenia Muscle. 2018; 9: 453-464
        • Charlson F.J.
        • Baxter A.J.
        • Dua T.
        • Degenhardt L.
        • Whiteford H.A.
        • Vos T.
        Excess mortality from mental, neurological, and substance use disorders in the Global Burden of Disease Study 2010.
        in: 3rd ed. Mental, Neurological, and Substance Use Disorders: Disease Control Priorities. Vol 4. World Bank, Washington, DC2016: 41-66
        • Pikora T.J.
        • Bourke J.
        • Bathgate K.
        • Foley K.R.
        • Lennox N.
        • Leonard H.
        Health conditions and their impact among adolescents and young adults with Down syndrome.
        PLoS One. 2014; 9: e96868
        • Sipes M.
        • Matson J.L.
        • Belva B.
        • Turygin N.
        • Kozlowski A.M.
        • Horovitz M.
        The relationship among side effects associated with anti-epileptic medications in those with intellectual disability.
        Res Dev Disabil. 2011; 32: 1646-1651
        • Hermans H.
        • Evenhuis H.M.
        Factors associated with depression and anxiety in older adults with intellectual disabilities: results of the Healthy Ageing And Intellectual Disabilities Study.
        Int J Geriatr Psychiatry. 2013; 28: 691-699
        • Colver A.
        • Rapp M.
        • Eisemann N.
        • et al.
        Self-reported quality of life of adolescents with cerebral palsy: a cross-sectional and longitudinal analysis.
        Lancet. 2015; 385: 705-716
        • Groh W.J.
        Arrhythmias in the muscular dystrophies.
        Heart Rhythm. 2012; 9: 1890-1895
        • Van Der Slot W.M.
        • Nieuwenhuijsen C.
        • Van Den Berg-Emons R.J.
        • et al.
        Chronic pain, fatigue, and depressive symptoms in adults with spastic bilateral cerebral palsy.
        Dev Med Child Neurol. 2012; 54 ([published correction appears in Dev Med Child Neurol. 2012;54(11):1064]): 836-842
        • Peterson M.D.
        • Kamdar N.
        • Hurvitz E.A.
        Age-related trends in cardiometabolic disease among adults with cerebral palsy.
        Dev Med Child Neurol. 2019; 61: 484-489
        • Smith K.J.
        • Peterson M.D.
        • O’Connell N.E.
        • et al.
        Risk of depression and anxiety in adults with cerebral palsy.
        JAMA Neurol. 2019; 76 ([published correction appears in JAMA Neurol. 2019;76(8):986]): 294-300
        • Peterson M.D.
        • Ryan J.M.
        • Hurvitz E.A.
        • Mahmoudi E.
        Chronic conditions in adults with cerebral palsy.
        JAMA. 2015; 314: 2303-2305
        • Ryan J.M.
        • Peterson M.D.
        • Matthews A.
        • et al.
        Non-communicable disease among adults with cerebral palsy: a matched cohort study.
        Neurology. 2019; 93 (https://doi.org/10.1212/WNL.0000000000008199): e1385-e1396
        • Berry J.G.
        • Berry S.D.
        Caring for patients with neurological impairment: conversations between a pediatrician and geriatrician.
        JAMA Pediatr. 2018; 172: 796
        • Ahmedani B.K.
        • Hock R.M.
        Health care access and treatment for children with co-morbid autism and psychiatric conditions.
        Soc Psychiatry Psychiatr Epidemiol. 2012; 47: 1807-1814
        • Vohra R.
        • Madhavan S.
        • Sambamoorthi U.
        • St Peter C.
        Access to services, quality of care, and family impact for children with autism, other developmental disabilities, and other mental health conditions.
        Autism. 2014; 18: 815-826
        • Aisen M.L.
        • Kerkovich D.
        • Mast J.
        • et al.
        Cerebral palsy: clinical care and neurological rehabilitation.
        Lancet Neurol. 2011; 10: 844-852
        • Whiteford H.A.
        • Degenhardt L.
        • Rehm J.
        • et al.
        Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.
        Lancet. 2013; 382: 1575-1586
        • GBD 2017 Disease and Injury Incidence and Prevalence Collaborators
        Global, regional, and national incidence, prevalence, and years lived with disabilitity for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
        Lancet. 2018; 392 ([published correction appears in Lancet. 2019;393(10190):e44]): 1789-1858
        • Wilkinson D.A.
        • Johnson K.
        • Garton H.J.
        • Muraszko K.M.
        • Maher C.O.
        Trends in surgical treatment of Chiari malformation Type I in the United States.
        J Neurosurg Pediatr. 2017; 19: 208-216
        • Borza T.
        • Jacobs B.L.
        • Montgomery J.S.
        • et al.
        No differences in population-based readmissions after open and robotic-assisted radical cystectomy: implications for post-discharge care.
        Urology. 2017; 104: 77-83
        • Stem M.S.
        • Blachley T.S.
        • Shtein R.M.
        • Herman W.H.
        • Gardner T.W.
        • Stein J.D.
        Impact of diagnosing diabetic complications on future hemoglobin A1c levels.
        J Diabetes Complications. 2016; 30: 323-328
        • Quiñones A.R.
        • Markwardt S.
        • Botoseneanu A.
        Multimorbidity combinations and disability in older adults.
        J Gerontol A Biol Sci Med Sci. 2016; 71: 823-830
        • Salive M.E.
        Multimorbidity in older adults.
        Epidemiol Rev. 2013; 35: 75-83
        • GBD 2017 DALYs and HALE Collaborators
        Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
        Lancet. 2018; 392 ([published correction appears in Lancet. 2019;393(10190):e44]): 1859-1922
        • Peterson M.D.
        • Gordon P.M.
        • Hurvitz E.A.
        Chronic disease risk among adults with cerebral palsy: the role of premature sarcopoenia, obesity and sedentary behaviour.
        Obes Rev. 2013; 14: 171-182
        • Peterson M.D.
        • Gordon P.M.
        • Hurvitz E.A.
        • Burant C.F.
        Secondary muscle pathology and metabolic dysregulation in adults with cerebral palsy.
        Am J Physiol Endocrinol Metab. 2012; 303: E1085-E1093
        • Whitney D.G.
        • Shapiro D.N.
        • Warschausky S.A.
        • Hurvitz E.A.
        • Peterson M.D.
        The contribution of neurological disorders to the national prevalence of depression and anxiety problems among children and adolescents.
        Ann Epidemiol. 2019; 29: 81-84.e2
        • US Preventive Services Task Force
        Screening for osteoporosis to prevent fractures: US Preventive Services Task Force recommendation statement.
        JAMA. 2018; 319: 2521-2531
        • Tumin D.
        Marriage trends among Americans with childhood-onset disabilities, 1997-2013.
        Disabil Health J. 2016; 9: 713-718
        • Pine D.S.
        • Cohen P.
        • Gurley D.
        • Brook J.
        • Ma Y.
        The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders.
        Arch Gen Psychiatry. 1998; 55: 56-64
        • Jacobson N.C.
        • Newman M.G.
        Anxiety and depression as bidirectional risk factors for one another: a meta-analysis of longitudinal studies.
        Psychol Bull. 2017; 143: 1155-1200

      Linked Article

      • In the Limelight: February 2020
        Mayo Clinic ProceedingsVol. 95Issue 2
        • Preview
          This monthly feature highlights three articles in the current print and online issue of Mayo Clinic Proceedings. These articles are also featured on the Mayo Clinic Proceedings’ YouTube Channel ( https://youtu.be/vHUmlFhFfeE ).
        • Full-Text
        • PDF